Fluticasone Furoate+Vilanterol is used in the treatment of Chronic obstructive pulmonary disease (COPD) and Asthma.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Bilexa 200 Inhalation Capsule, classified as a respiratory stimulant, is employed to address asthma and chronic obstructive pulmonary diseases (COPD). Asthma, characterized by bronchial airway constriction, results in breathing difficulties, often marked by wheezing. COPD encompasses lung diseases like emphysema and chronic bronchitis, leading to restricted airways. The inhaler contains Fluticasone Furoate (an inhaled corticosteroid) and Vilanterol (a long-acting beta-agonist or LABA).
Consult your doctor regarding the use of Bilexa 200 Inhalation Capsule during pregnancy, as information is not available.
Consult your doctor about the use of Bilexa 200 Inhalation Capsule during breastfeeding, as information is not available.
It is not known whether Bilexa 200 Inhalation Capsule affects the ability to drive. Avoid driving if you experience symptoms that impact concentration and reaction.
Bilexa 200 Inhalation Capsule is considered safe for use in patients with kidney disease. No dose adjustment is recommended.
Exercise caution when using Bilexa 200 Inhalation Capsule in patients with liver disease. Dose adjustment may be necessary; consult your doctor for guidance.
Bilexa 200 Inhalation Capsule is a combination of fluticasone furoate and vilanterol. Fluticasone furoate works by blocking the production of certain chemicals in the body thatreathing easier.
Common side effects of COPD include nasopharyngitis, upper respiratory tract infection, headache, and oral candidiasis. For asthma, common side effects include nasopharyngitis, oral candidiasis, headache, and influenza.
Bilexa Inhalation Capsule is indicated for the long-term, once-daily maintenance treatment of airflow obstruction and for reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD). It is also used once daily for the treatment of asthma in patients aged 18 years and older. The composition includes Vilanterol 25 mcg (as Vilanterol Trifenatate INN) and Fluticasone Furoate INN 100 mcg or 200 mcg, depending on the variant.
Vilanterol Trifenatate is a selective, long-acting beta-2 agonist, and Fluticasone Furoate is a corticosteroid with glucocorticoid activity. The combination works to provide therapeutic effects in the treatment of COPD and asthma by addressing airway obstruction and inflammation.
Dosage and administration involve oral inhalation, and the capsule should not be swallowed. The recommended dosage for maintenance treatment of COPD is 1 inhalation of 25/100 mcg once daily, and for asthma, it is 1 inhalation of 25/100 mcg or 25/200 mcg once daily.
The inhalation capsule may interact with other medications, and caution is advised with strong cytochrome P450 3A4 inhibitors, monoamine oxidase inhibitors, tricyclic antidepressants, beta-blockers, and diuretics.
Contraindications include primary treatment of status asthmaticus or acute episodes of COPD or asthma requiring intensive measures and severe hypersensitivity to milk proteins or any ingredients.
The use of Bilexa Inhalation Capsule during pregnancy and lactation requires further data.
Storage conditions involve avoiding direct sunlight or heat, storing in a cool and dry place, and keeping it away from the eyes.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.